Philadelphia, PA (October 12, 2020) – Oncoceutics, Inc. announced that the European Patent Office has issued a Decision to Grant…
Andrzej Jakubowiak, MD, Ph.D. of the University of Chicago Comprehensive Cancer Center speaks on the ASCO 2020 abstract Orvacabtagene autoleucel…
Robert Coleman, MD, FACOG, FACS, Chief Scientific Officer U.S. Oncology Research discusses Elevation Oncology and US Oncology Research Announce Collaboration…
Paul G. Richardson, MD of Dana-Farber Cancer Institute explains the abstract entitled First-in-human phase I study of the novel CELMoD…
Alexander Stratigos, M.D., Professor of Dermatology/Or Investigator of the University of Athens Medical School at Andreas Sygros Hospital explains the…
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr.…
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr.…
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr.…
Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón producidos en español para nuestra comunidad…
Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón producidos en español para nuestra comunidad…
Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón producidos en español para nuestra comunidad…
Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón, producida en español para nuestra comunidad…
Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón producidos en español para nuestra comunidad…
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr.…
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr.…
For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director…
For the GRACE Blood Cancer Video Library, Dr. Marco Ruiz, Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, Myelodysplastic…
For the GRACE Blood Cancer Video Library, Dr. Marco Ruiz, Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, Myelodysplastic…
For the GRACE Blood Cancer Video Library, Dr. Marco Ruiz, Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, Myelodysplastic…
For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director…
For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director…
For this video Dr.Matthew Gubens discusses targeted therapies in non small cell lung cancer. What are the leading treatment options…
For this video Dr.Matthew Gubens discusses non small cell lung cancer, and immunotherapy. For a frail patient with advanced NSCLC,…
For this video Dr.Matthew Gubens discusses non small cell lung cancer, and tumor mutational burden. At this time could TMB…
For this video Dr. Millie Das discusses Immunotherapy in non small cell lung cancer., and the current role of immunotherapy…
For this series of the GRACE Lung Cancer Video Library, Dr. Millie Das joined us to discuss targeted therapies in…
For the GRACE Lung Cancer Video Library, Dr. Millie Das joined us to discuss Immunotherapy in non small cell lung…
Prof. Jean Bourhis, Department Head of Radio-Oncology at the University Hospital of Lausanne and Lead Investigator of Centre Hospitalier Universitaire…
Aditya Bardia, MD, MPH of Massachusetts General Hospital discusses the Natera Announces Collaboration with Massachusetts General Hospital for a Prospective…
Aditya Bardia, MD, MPH of Dana-Farber Cancer Institute speaks about ESMO 20 ASCENT: A randomized phase III study of sacituzumab…
Andrea B. Apolo, MD of NIH National Cancer Institute speaks about the ESMO 2020 abstract New First-Line Treatment Option For…
Angel A. Rodriguez, MD, Oncology Medical Director of Natera speaks about Natera Announces Collaboration with Massachusetts General Hospital for a…
Roy S Herbst, MD, Ph.D. of the Yale School of Medicine and Yale Cancer Center discusses ESMO 2020 abstract Yale…
Timothy A. Yap, MD of MD Anderson discusses ESMO 2020 Poster: Rucaparib + Sacituzumab Govitecan: Initial Data From the Phase…
Dr. Zeynep Zengin, post-doctoral fellow at City of Hope discusses the ESMO Virtual Congress 2020: Assessment of Circulating Cell-Free Tumor…
Professor Ray McDermott of St. Vincent University Hospital and Tallaght Hospital, Ireland discusses ESMO – Survival benefits of larotrectinib in…
Professor Ray McDermott of St. Vincent University Hospital and Tallaght Hospital, Ireland explains the ESMO poster DASL-HiCaP: Darolutamide augments standard…
Peter R. Galle, MD of University Medical Center Mainz discusses his ESMO 2020 abstract – Updated results of a phase…
W. Michael Korn, MD, CMO of Caris Life Sciences discusses their abstract – Caris Life Sciences Presented New Ovarian Cancer…
Jacob J. Adashek, DO of the Moffitt Cancer Center explains the ESMO 2020 Abstract – Personalized molecularly matched therapies for…
Roy S Herbst, MD, Ph.D. of Yale Cancer Center explains the ESMO abstract – Yale Cancer Center Study Reinforces Benefit…
Ana Maria Arance Fernandez, MD of Hospital ClÃnic de Barcelona, Barcelona, Spain speaks on her ESMO abstract – LBA44 -…
Alexander Eggermont, MD of Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay explains the ESMO 2020 abstract LBA46 -…
Zarnie Lwin, MD Royal Brisbane, and Women’s Hospital, University of Queensland discusses the ESMO abstract LBA41 – LEAP-005: Phase II…
John Bridgewater, MD, Ph.D., Medical Oncologist discusses ESMO abstracts Efficacy and Safety of Futibatinib in Intrahepatic Cholangiocarcinoma (iCCA) Harboring FGFR2…
Dr. Neal Shore MD, FACS, CPI, of the Atlantic Urology Clinics and Director at the Carolina Urologic Research Center, discusses…
Susanna Curtis, MD of Yale School of Medicine and Yale Cancer Center speaks about the Study: Medical Marijuana Associated with…
Erika P. Hamilton, MD Director, Breast Cancer and Gynecologic Cancer Research Program, Sarah Cannon Research Institute at Tennessee Oncology speaks…
Neal Shore, MD at the Carolina Urologic Research Center discusses the ESCALATE Trial Potential Enhancement of Prostate Cancer Treatment Options:…
Lillian Siu, MD of the Princess Margaret Cancer Centre discusses ESMO 2020 abstract #524O, Proffered Paper: Initial Results of a…
Eric Jonasch, MD The University of Texas MD Anderson Cancer Center ASCO 2020 Phase II study of the oral HIF-2α…
Robert Coleman, MD, FACOG, FACS, Chief Scientific Officer US Oncology Research discusses ASCO 2020 A phase III randomized controlled trial…
Erik A. Williams, MD of the Foundation Medicine, Inc. discusses CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1–Wild-Type Tumor…
Paolo Ghia, MD, Ph.D. of Università Vita-Salute San Raffaele speaks about ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib…
Xiang Cheng Ph.D. and Feng Geng Ph.D. from Ohio State University Comprehensive Cancer Center discusses Blocking Fat Storage Might Offer…
S. Michelle Shiller, DO, AP/CP, MGP at PathGroup discusses how the Pan-Cancer Consortium Moves to Clarify and Promote Consistent Use…
Ari Melnick, MDof Weill Cornell Medicine discusses winning the  American Society of Hematology Ernest Beutler Lecture and Prize. ASH will award…
Edward J. Benz, Jr., MD at Dana Farber discusses his award from American Society of Hematology Leadership in Promoting Diversity…
Ammar Chaudhry, MD at City of Hope discusses an abstract from AACR 2020 entitled Randiomic prediction of survival in recurrent…
Shailja Shah, MD, MPH. at Vanderbilt Ingram Cancer Center discusses a Study which gauges specific site gastric cancer risks among…
Nick Smith-Stanley, MBA, Associate Director of Administration & Strategic Planning of the LIVESTRONG Cancer Institutes, Dell Medical School speaks about…
Michael Wang, MD at MD Anderson discusses Kite Pharma’s FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed…
Greg Hiebert, Leadership Educator, Coach, and Consultant of Leadership Forward discusses Leadership Resilience and Post Traumatic Growth & Live. Great…
David R. Gandara, MD at MDAnderson discusses Guardant Health’s FDA approval of the Guardant360 CDx which delivers critical genomic information…
Minesh P Mehta MD, FASTRO @BaptistHealthSF High- vs Low-Dose Radiation for Adult Low-Grade Glioma
Miguel Ferreira, MSc of GlobalData discusses how the Hodgkin’s lymphoma market to suffer with Adcetris patent expiry but benefit from…
Stephen B. Edge MD, FACS, FASCO of Roswell Park Comprehensive Cancer Center speaks about the ASCO 2020 Going off pathway:…
Kazuhiko Matsuoka, PhD Medical University of Vienna Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni…
Mikkael Sekeres, MD @CleClinicMD @TakedaPharma FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic…
Melissa Ann Geller, MD of the University of Minnesota speaks about the ASCO 2020 abstract APOLLO: A phase I study…
Marwan Fakih, MD at City of Hope discusses an abstract from AACR20 entitled Efficacy and Safety of Pembrolizumab in Previously…
Anca Chelariu- Raicu, MD of MD Anderson Cancer Center speaks about the ASCO 2020 abstract Phase I/II study of weekly…
Jennifer Baker Flechtner, Ph.D. – Genocea Biosciences Inc’s Chief Scientific Officer discusses Genocea to Present Data that Reveal New Understanding…
J. Mel Sorensen, MD President, and Chief Executive Officer Galera Thereptutics, Inc gives an overview from ASCO 2020 abstract entitled…
Petros Grivas, MD, PhD Seattle Cancer Care Alliance discusses FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with…
Jonathan Cheng, MD Merck – Vice President Clinical Research discusses KEYTRUDA Is the First Single-Agent, Anti-PD-1 Therapy Approved for the…
Aurélien Marabelle, MD at Gustave Roussy discusses the FDA Approval of Second Biomarker-Based Indication for Pembrolizumab (KEYTRUDA) The FDA issued…
Chandra Belani, MD Chief Science Officer – IASLC discusses IASLC: New Lung Cancer Screening Guidelines Will Save Lives Scientists have…
Hui Li, PhD at Univeristy of Virginia UVA IDs Gene Responsible for Deadly Glioblastoma Scientists have found an oncogene (a…
Wendy Stock, MD of University of Chicago receives 2020 Mentor Award Recipient The Anjuli Seth Nayak Professor of Leukemia at…
Sigrun Hallmeyer, MD at ACCC discusses Immuno-Oncology and What Lies Ahead
Michael Wang, MD from MD Anderson discusses a paper from Nature entitled Durable response with single-agent acalabrutinib in patients with…
Steve Shak Exact Sciences Chief Medical Officer discusses Oncotype DX Genomic Prostate Score® Result Shows for the First Time the…
Timothy A. Yap, MD from MD Anderson discusses an abstract from Journal of Clinical Oncology entitled Phase I Trial of…
Christopher Jakubowski, MD The Johns Hopkins discusses an abstract from The Journal of Clinical Oncology entitled Response to Crizotinib in…
Murray Brunt, MBBS, FRCR, FRCP The Institute of Cancer discusses an article in The Journal of Clinical Oncology entitled Ten-Year…
Daniel Persky, MD @UAZCance #ASCO20 Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup…
Dan Paul Zandberg, MD at UPMC discusses an ASCO 2020 abstract entitled The impact of tumor hypoxia on the clinical…
Ari Rosenberg, MD at The University of Chicago discusses an abstract from ASCO 2020 entitled Dose and volume de-escalation for…
Professor Galina Velikova, MD of the Leeds Institute of Medical Research discusses the ASCO abstract Phase III randomized controlled trial…
Jingxuan Zhao, MPH @AmercianCancer #ASCO20 Health insurance status and cancer stage at diagnosis and survival in the United States Bottom…
Paz J. Vellanki, MD from U.S. Department of Health and Human Services discusses an ASCO 2020 abstract entitled Evaluation of…
Nikhil C. Munshi, MD of Dana-Farber Cancer Institute discusses ASCO20 Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in…
Lillian Siu, MD Princess Margaret Cancer Centre discusses an ASCO 2020 abstract entitled Phase III LEAP-010 study: first-line pembrolizumab with…
Bruno Sangro, MD, Ph.D. at Clinica Universidad de Navarro discusses The unmet need in HCC patients, the ADP-A2AFP complete response…
Manisha H Shah, MD of The James Ohio State University Comprehensive Cancer Center explains the study: Dabrafenib, Trametinib, and IMRT…
Andrew Wei, MBBS, Ph.D. Alfred Hospital and Monash University U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New…
Catherine Haring, MD & Paul Swiecicki, MD from University of Michigan Medical School discuss an ASCO 2020 abstract entitled HPV…
Ralph Zinner, MD University of Kentucky discusses an ASCO 2020 abstract entitled Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and…
Manisha H Shah, MD of The James Ohio State University Comprehensive Cancer Center discusses the Efficacy of Selpercatinib in RET-Altered…
Jan Ole Kemnade, MD, Ph.D. from Baylor College of Medicine discusses and ASCO 2020 abstract entitled Computational discovery of non-mutational…
Rebecca Christian Arend, MD at University of Alabama discusses an abstract from ASCO 2020 Clinical trial in progress: Pivotal study…
Michelle Echevarria, MD from Moffitt Cancer Center discusses an ASCO 2020 Phase I dose escalation of stereotactic body radiation therapy…
Kedar Kirtane, MD from Moffitt Cancer Center discusses an ASCO 2020 abstract entitled Concurrent cetuximab (CTX) and nivolumab (NIVO) in…
Kathleen N. Moore, MD from OU Medicine discusses an ASCO 2020 abstract entitled MIRASOL (GOG 3045/ENGOT OV-55): A randomized, open-label,…
Denise Manon Langabeer, MBA, Ph.D. of MD Anderson gives an overview from ASCO 2020 the abstract entitled Are symptoms distinguishable…
Ben George, MD from Froedtert & Medical College discusses an ASCO 2020 abstract entitied A phase I, first-in-human, open-label, dose‑escalation,…
Shannon N. Westin, M.D., M.P.H., F.A.C.O.G. from MD Anderson discusses an ASCO 2020 abstract entitled – DUO-E/GOG-3041/ENGOT-EN10: a randomized phase…
Mansoor Raza Mirza, MD from Region Hovedstaden discusses an abstract from ASCO 2020 entitled Final survival analysis of Smita Bhatia,…
Jan Schellens, MD, CMO Byondis discusses the Phase I Study of Antibody-Drug Conjugate SYD1875. 11 August 2020, Nijmegen, The Netherlands,…
Mansoor Raza Mirza, MD from Region Hovedstaden discusses an abstract from ASCO 2020 entitled Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination…
Andreas Burchert, MD University Hospital Giessen and Marburg Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia…
Sepideh Azarianpour-Esfahani, Ph.D. of Case Western Reserve University discusses an abstract from ASCO 2020 Computerized features of spatial arrangement of…
Nicolo Manaresi, Ph.D. Chief Scientific Officer of M Silicon Biosystems gives an overview of Two Studies Presented at AACR 20…
Allison Huegel, COO AxoProtego and Ahmet Hoke, MD, Ph.D. Johns Hopkins Medicine gives an overview of AxoProtego Therapeutics Announces Novel…
John R. “Jack†Steel, M.D. F.A.C.R.O. of Tampa Bay Radiation Oncology discusses Managing Anxiety During Cancer Treatment. Some of the…
David Spetzler, M.S., Ph.D., MBA, President and Chief Scientific Officer of Caris Life Sciences discusses their Partners with Elevation Oncology…
Rana R. McKay, MD UC SD Health discusses ASCO 2020 abstract entitled Optimized management of nivolumab (Nivo) and ipilimumab (Ipi)…
Benoit You, MD, Ph.D. from Centre Hospitalier Lyon-Sud discusses an ASCO 2020 abstract entitled ROPHIMMUN phase II trial, cohort A…
Babar Bashir, MD from Jefferson Health discussed an ASCO 2020 abstract entitled BT5528-100 phase I/II study of the safety, pharmacokinetics,…
Johanna C. Bendell, MD from Sarah Cannon discusses and ASCO 2020 abstract entitled A phase I/II, two-part, multicenter, first-in-human study…
Ramaprasad Srinivasan, M.D., Ph.D. – NIH National Cancer Institute Results from a phase II study of bevacizumab and erlotinib in…
David A. Braun, MD, PhD from Dana Farber discusses an ASCO 2020 abstract entitled Immunogenomic characterization of advanced clear cell…
Paola Nix, Ph.D. at Myriad Genetics discusses an ASCO 2020 abstract entitled Functional RNA Studies Are a Useful Tool in…
Thanh Hue Dellinger, MD from the City of Hope discusses an ASCO 2020 abstract entitled Whole transcriptome changes correlate to…
Patrick Glen Pilie, MD MD Anderson discusses an ASCO 2020 abstract entitled Identifying Functional Loss of ATM Gene In Patients…
Matthew Galsky, MD from Mount Sinai Tisch Cancer discusses an ASCO 2020 abstract entitled Phase III IMvigor 130 Study Tumor,…
Eleni Efstathiou, MD, Ph.D. of MD Anderson discusses an ASCO 2020 abstract entitled Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with…
Ajay Goel, Ph.D. of the City of Hope speaks about the AACR 2020 Abstract 1084: EpiPanGI-Dx: A cell-free DNA methylation…
David Spigel, MD at Sarah Cannon discusses an ACCC 2020 presentation entitled Results Show Multidisciplinary Team Approach Needed for Best…
Nancy Beatriz Gordon, MD from MD Anderson discusses an abstract from ASCO 2020 entitled A Phase I Trial Of Aerosol…
Istvan Petak, MD #ASCO20 Oncompass Medicine SHIVA01 Trial Update Context: Precision oncology demands that individual molecular pathomechanisms be identified in…
Scott Kopetz, MD at MD Anderson discusses the FDA Approval Encorafenib) In Combination With Cetuximab For The Treatment Of Brafv600E-Mutant…
Sonny Hsiao, Ph.D. of Acopedia shares his final thoughts on Acepodia Presents Preclinical Data on its Lead NK Cell Therapy…
Sonny Hsiao, Ph.D. of Acopedia discusses Acepodia Presents Preclinical Data on its Lead NK Cell Therapy Candidate ACE1702 at 2020…
Alessandro Santin, MD of Byondis shares his final thoughts on the study: Byondis Initiates Phase II Study of Antibody-Drug Conjugate…
Alessandro Santin, MD of Byondis talks about what are the next steps for the study: Byondis Initiates Phase II Study…
Alessandro Santin, MD of Byondis speaks about will this affect clinicians today on the study: Byondis Initiates Phase II Study…
Jeff Ross, MD at Foundation Medicine discusses an ASCO 2020 abstract entitled Clinically aggressive malignancies associated with STK11 germline mutations…
Theresa Deisher PhD at AVM Biotechnology discusses The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma Description in detail:…
Christian Marsolais @Theratech_ #AACR20 NEW DATA SHOW THERATECHNOLOGIES’ SORT1+ TECHNOLOGY IS EFFECTIVE IN MANY TREATMENT-RESISTANT CANCERS The optimisation of the…
Alessandro Santin, MD of Byondis answers common questions on the study: Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab…
Alessandro Santin, MD of Byondis talks about the study: Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced…
Ignacio Garrido-Laguna, MD at Huntsman Cancer Institute discusses the ASCO 2020 abstract entitled A phase I, first-in-human, open-label, dose‑escalation, safety,…
Oliver Peacock, MD The University of Texas MD Anderson Cancer Center gives his final thoughts about his ASCO 2020 Abstract…
Oliver Peacock, MD The University of Texas MD Anderson Cancer Center answers common questions he has received for his ASCO…
Oliver Peacock, MD The University of Texas MD Anderson Cancer Center discusses his ASCO 2020 Abstract on Improving the AJCC/TNM…
Philip Mack, Ph.D. of Mount Sinai answers the common questions he has received for his ASCO 2020 abstract on Residual…
Philip Mack, Ph.D. of Mount Sinai discusses his ASCO 2020 abstract on Residual circulating tumor DNA (ctDNA) after two months…
Senthil Damodaran, MD of MD Anderson shares his final thoughts on the Phase II study of copanlisib in patients with…
Senthil Damodaran, MD of MD Anderson talks about the common questions he receives about the Phase II study of copanlisib…
Wilson H. Miller, MD Jewish General Hospital discusses an ASCO 2020 abstract entitled A phase Ib study of oral Chk1…
Senthil Damodaran, MD of MD Anderson explains the Phase II study of copanlisib in patients with tumors with PIK3CA mutations…
Jason P Sheehan, MD of the University of Virginia speaks about his final thoughts on the Focused Ultrasound Shows Potential…
Lindsey Rolfe at Clovis Oncology outlines a New Preclinical Data on ALKS 4230 in Combination With Lucitanib The research assessed…
Jason P Sheehan, MD of the University of Virginia explains how this will affect clinicians today, the Focused Ultrasound Shows…
Jason P Sheehan, MD of the University of Virginia discusses the common questions he receives about the Focused Ultrasound Shows…
Daniel Becker MD at NYU Langone discusses an ASCO 2020 abstract entitled Exploring the Cancer Genome Atlas (TCGA) for the…
Jason P Sheehan, MD of the University of Virginia discusses the Focused Ultrasound Shows Potential Against Deadliest Brain Tumor. The…
Kristen Hege, MD – Bristol Myers Squibb discusses Phase 1 proof-of-concept data (via an oral presentation) on novel CELMoD CC-92480…
Filip Janku, MD at MD Anderson discusses an ASCO 2020 abstract entitled Phase I study of IM156, a novel potent…
Kristen Hege, MD – Bristol Myers Squibb discusses Phase 1 proof-of-concept data (via an oral presentation) on novel CELMoD CC-92480…
Haiying Cheng, MD at Albert Einstein Cancer Center discusses an ASCO 2020 abstract entitled RICTOR amplification as a novel therapeutic…
Philip McCarthy, MD of Roswell Park discusses New Strategy for Controlling Graft vs. Host Disease in Blood/Marrow Transplant Recipients. New…
Charles Edward Geyer, MD Houston Methodist discusses the ASCO 2020 abstract entitled Biomarker data from KATHERINE: A phase III study…
Jacob J. Adashek, DO of Moffit Cancer Center gives an overview from ASCO 2020 the abstract entitled Targetable immune checkpoint…
Ravi Salgia, MD, PhD from City of Hope and the AACR 2020 meeting discusses the AACR 2020 abstract entitled Association…
Cathy Eng, MD at Vanderbilt University Medical Center discusses Anal cancer’s first randomized trial for inoperable disease sets the treatment…
Scott Tomlins, MD, Ph.D. Co-Founder, and Chief Scientific Officer – Strata discusses the Strata Oncology Partners with Elevation Oncology to…
Audrey Guth, Nanny Angel Network – Astellas Oncology discusses Astellas Oncology Opens Annual C3 Prize® Call for Entries to Award…
Eric Jonasch, MD @MDAndersonNews #ASCO2020 gives an overview of the Phase II study of the oral HIF-2α inhibitor MK-6482 for…
Abby Westerman, founder of b-present Foundation – Astellas discusses Astellas Oncology Opens Annual C3 Prize® Call for Entries to Award…
Elizabeth Plimack, MD @FoxChaseCancer gives an updated analysis of KEYNOTE-426 at ASCO 2020 Pembrolizumab plus axitinib versus sunitinib as first-line…
Jared Gollob Chief Medical Officer @KymeraTx shares common questions he gets from colleagues such as “What’s Advantage of IRAK 4…
Jared Gollob @JaredGollob @KymeraTx gives an overview of a poster presented at AACR 2020 IRAKIMiD Degrader Program and Present Preclinical…
Astrid Margossian, MD @SEngineMedicine discusses an ASCO 2020 poster entitled Predictive value of a CLIA-approved organoid based drug sensitivity test…
Andy Krivoshik, MD, Ph.D. – Astellas Oncology discusses Astellas Oncology Opens Annual C3 Prize® Call for Entries to Award the…
Robin Kate Kelley, MD of the University of California, San Francisco discusses the most effective way to combined a CTL4…
Robin Kate Kelley, MD gives an overview of a presentation from ASCO 2020 entitled Efficacy, tolerability, and biologic activity of…
Charles S. Fuchs, MD, MPH at Yale Cancer discusses how Checkpoint Inhibitors are a “real player” in Gastric Cancers. Bottom…
Charles S. Fuchs, MD, MPH at Yale Cancer discusses the Current Role for Pembrolizumab in Gastric Cancer using the latest…
Charles S. Fuchs, MD, MPH at Yale Cancer gives an overview of a study presented at ASCO 2020 entitled Pembrolizumab…
Benjamin Tycko, MD of Hackensack Meridian Health explains his study findings on DNA that Pinpoint Risks for Cancers. By sequencing…
Benjamin Tycko, MD of Hackensack Meridian Health explains Classical Cancer Epigenetic vs Epigenetic Mapping. By sequencing entire genomes for DNA…
Benjamin Tycko, MD gives an overview of Signposts in DNA that Pinpoint Risks for Cancers and other Diseases. By sequencing…
First Lady Melania Trump chairs a White House roundtable discussing sickle cell anemia.Â
Marian Navratil, P.h.D. of HTG Molecular Diagnostics discusses the power of RNA profiling now and in the future. This data…
Marian Navratil, P.h.D. of HTG Molecular Diagnostics discusses the future of RNA profiling and using it for detecting inflammation of…
Marian Navratil, P.h.D. of HTG Molecular Diagnostics How HGT is Different than RNAPlatform comparison of HTG EdgeSeq and RNA-Seq for…
Marian Navratil, P.h.D. of HTG Molecular Diagnostics gives an overview from ASCO 2020 the Platform comparison of HTG EdgeSeq and…
Melissa Johnson, MD, Associate Director, Lung Cancer Research and Drug Development, Sarah Cannon Research Institute at Tennessee Oncology discusses CX-2029,…
Kathryn Lang, MD – Guardant Health, is this available today. The data presented at the AACR 2020 show that the…
Kathryn Lang, MD of Guardant Health discusses Restricting Cohort to Negative Test Results with Liquid Biopsy Highly Accurate in Detecting…
Kathryn Lang, MD of Guardant Health provides an overview of data presented at AACR 2020 that shows that the LUNAR-2…
Melissa Johnson, MD, Associate Director, Lung Cancer Research and Drug Development, Sarah Cannon Research Institute at Tennessee Oncology discusses CX-2029,…
Jason P Sheehan, MD – University of Virginia discusses the Focused Ultrasound Shows Potential Against Deadliest Brain Tumor https://news.virginia.edu/content/focused-ultrasound-shows-potential-against-deadliest-brain-tumor
Jason P Sheehan, MD – University of Virginia discusses the Focused Ultrasound Shows Potential Against Deadliest Brain Tumor https://news.virginia.edu/content/focused-ultrasound-shows-potential-against-deadliest-brain-tumor
Jason P Sheehan, MD – University of Virginia discusses the Focused Ultrasound Shows Potential Against Deadliest Brain Tumor https://news.virginia.edu/content/focused-ultrasound-shows-potential-against-deadliest-brain-tumor
Jason P Sheehan, MD – University of Virginia discusses the Focused Ultrasound Shows Potential Against Deadliest Brain Tumor https://news.virginia.edu/content/focused-ultrasound-shows-potential-against-deadliest-brain-tumor
Debra L. Richardson, MD – Sarah Cannon discusses Phase I expansion study of XMT-1536, a novel NaPi2b-targeting antibody-drug conjugate (ADC):…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
Guillermo Garcia-Manero, MD – MD Anderson Cancer Center discusses Astex Pharmaceuticals, Taiho Oncology, and Otsuka Pharmaceutical announce FDA and Health…
Guillermo Garcia-Manero, MD – MD Anderson Cancer Center discusses Astex Pharmaceuticals, Taiho Oncology, and Otsuka Pharmaceutical announce FDA and Health…
Guillermo Garcia-Manero, MD – MD Anderson Cancer Center discusses Astex Pharmaceuticals, Taiho Oncology, and Otsuka Pharmaceutical announce FDA and Health…
Mohamed Alaa Gouda, MD MD Anderson discusses Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of…
Mohamed Alaa Gouda, MD MD Anderson discusses Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of…
Quincy S. Chu, MD – University of Alberta discusses A phase Ib study of oral Chk1 inhibitor LY2880070 in combination…
Quincy S. Chu, MD – University of Alberta discusses A phase Ib study of oral Chk1 inhibitor LY2880070 in combination…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
Daniel Spakowicz, PhD – The James – Ohio State University Comprehensive Cancer Center discusses Microbiome Might Reveal Whether Immune Therapy…
Daniel Spakowicz, PhD – The James – Ohio State University Comprehensive Cancer Center discusses Microbiome Might Reveal Whether Immune Therapy…
Daniel Spakowicz, PhD – The James – Ohio State University Comprehensive Cancer Center discusses Microbiome Might Reveal Whether Immune Therapy…
Daniel Spakowicz, PhD – The James – Ohio State University Comprehensive Cancer Center discusses Microbiome Might Reveal Whether Immune Therapy…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Rodney Paul Rocconi, MD University of South Alabama discusses A phase I combination study of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy…
Rodney Paul Rocconi, MD University of South Alabama discusses A phase I combination study of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy…
Rodney Paul Rocconi, MD University of South Alabama discusses A phase I combination study of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy…
Shilpa Gupta, MD – Cleveland Clinic discusses Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers – Abstract 5019 and Abstract…
Shilpa Gupta, MD – Cleveland Clinic discusses Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers – Abstract 5019 and Abstract…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Anne Harris, MHP Childrens Minnesota discusses Juvenile granulosa cell tumor: An interim report from the international ovarian and testicular stromal…
Heather Losey, Ph.D., Director, Program Lead in Immuno-Oncology and Jared Lopes, Ph.D., Principal Scientist – Alkermes discusses New Preclinical Data…
Heather Losey, Ph.D., Director, Program Lead in Immuno-Oncology and Jared Lopes, Ph.D., Principal Scientist – Alkermes discusses New Preclinical Data…
Heather Losey, Ph.D., Director, Program Lead in Immuno-Oncology and Jared Lopes, Ph.D., Principal Scientist – Alkermes discusses New Preclinical Data…
John Pagel, MD Swedish Cancer Institute discusses Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal…
John Pagel, MD Swedish Cancer Institute discusses Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal…
John Pagel, MD Swedish Cancer Institute discusses Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal…
Brian Koffman, MD CLL Society Inc. discusses Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess MRD…
Brian Koffman, MD CLL Society Inc. discusses Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess MRD…
Brian Koffman, MD CLL Society Inc. discusses Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess MRD…